Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of N-(4-iodobenzoylamino)-5-ethyl-1,2,3,6-tetrahydropyridine as a treatment for cancer

Use of N-(4-iodobenzoylamino)-5-ethyl-1,2,3,6-tetrahydropyridine as a treatment for cancer

US Patent 10646479 · Granted May 12, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Substituted tetrahydroisoquinolines as anti-mitotic drug in triple negative brea2023
Substituted tetrahydroisoquinolines as anti-mitotic drug in triple negative brea2023
Substituted tetrahydroisoquinoline ethylbenzamide anti-cancer agents2020
N-substituted tetrahydroisoquinoline benzamides/benzene sulfonamides as anti-can2014
N-substituted tetrahydroisoquinoline benzamides/benzene sulfonamides as anti-can2014
N-aminotetrahydroisoquinolines as anti-cancer agents2013
N-aminotetrahydroisoquinolines as anti-cancer agents2013
N-aminopyrrolylmethyltetrahydropyridines as anti-cancer agents2013
N-aminopyrrolylmethyltetrahydropyridines as anti-cancer agents2013
Synthetic flavonoids and pharmaceutical compositions and therapeutic methods of 2012
Process for preparing 2,6-divinylpyridine and 2-methyl-6-vinylpyridine from 2,6-2005
Athletic garment1985